CAS 81552-34-3

Concanamicina C

Descrizione:

Concanamicina C è un prodotto naturale appartenente alla classe degli antibiotici macrolidi, specificamente derivato dalla fermentazione del batterio *Streptomyces griseus*. È noto per i suoi potenti effetti inibitori sulla ATPasi vacuolare (V-ATPasi), un enzima critica per vari processi cellulari, inclusa la regolazione del pH e il trasporto di nutrienti. Questa inibizione porta a effetti biologici significativi, rendendo Concanamicina C un composto prezioso nella ricerca, in particolare negli studi relativi al metabolismo cellulare e all'apoptosi. La sostanza presenta una struttura molecolare complessa caratterizzata da più anelli e gruppi funzionali, contribuendo alla sua attività biologica. Concanamicina C è tipicamente utilizzato in ambienti di laboratorio per esplorare i meccanismi di morte cellulare e per indagare potenziali applicazioni terapeutiche nel cancro e in altre malattie. La sua stabilità e solubilità in solventi organici lo rendono adatto a varie condizioni sperimentali. Tuttavia, come molti composti bioattivi, è essenziale un'attenta manipolazione e considerazione dei protocolli di sicurezza a causa dei suoi potenti effetti biologici.

Formula: C₄₅H₇₄O₁₃

InChI: InChI=1/C45H74O13/c1-13-16-34-28(7)37(56-38-22-33(46)42(50)31(10)55-38)23-45(52,58-34)30(9)41(49)29(8)43-35(53-11)18-15-17-24(3)19-26(5)39(47)32(14-2)40(48)27(6)20-25(4)21-36(54-12)44(51)57-43/h13,15-18,20-21,26-35,37-43,46-50,52H,14,19,22-23H2,1-12H3/b16-13+,18-15-,24-17-,25-20-,36-21+/t26?,27?,28?,29?,30?,31-,32?,33-,34?,35?,37?,38-,39?,40?,41?,42-,43?,45?/m1/s1

InChI key: InChIKey=XKYYLWWOGLVPOR-GKJVGUBMSA-N

SMILES: [C@@H]([C@@H]([C@H](C)[C@@]1([C@@H](OC)/C=C/C=C(\C)/C[C@@H](C)[C@H](O)[C@H](CC)[C@H](O)[C@H](C)/C=C(\C)/C=C(\OC)/C(=O)O1)[H])O)(C)[C@@]2(O)C[C@@H](O[C@H]3C[C@@H](O)[C@H](O)[C@@H](C)O3)[C@H](C)[C@@H](/C=C/C)O2

Sinonimi:

• (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-Dideoxy-β-<span class="text-smallcaps">D</span>-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propen-1-yl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyloxacyclooctadeca-3,5,13,15-tetraen-2-one
• 2,4-dideoxy-3-O-(2,6-dideoxy-α-D-arabino-hexopyranosyl)-1-C-{3-[(16E)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-2-hydroxy-1-methylbutyl}-4-methyl-5-[(1E)-prop-1-en-1-yl]pentopyranose
• 4'-O-De(aminocarbonyl)concanamycin A
• Concanamycin A, 4'-O-de(aminocarbonyl)-
• Concanamycin C
• Oxacyclooctadeca-3,5,13,15-tetraen-2-one, 18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-dideoxy-β-<span class="text-smallcaps">D</span>-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propen-1-yl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyl-, (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-
• Oxacyclooctadeca-3,5,13,15-tetraen-2-one, 18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-dideoxy-β-<span class="text-smallcaps">D</span>-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyl-, (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-
• Oxacyclooctadecane, concanamycin A deriv.
• (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-Dideoxy-β-D-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propen-1-yl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyloxacyclooctadeca-3,5,13,15-tetraen-2-one
• Oxacyclooctadeca-3,5,13,15-tetraen-2-one, 18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-dideoxy-β-D-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propen-1-yl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyl-, (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-
• Oxacyclooctadeca-3,5,13,15-tetraen-2-one, 18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(2,6-dideoxy-β-D-arabino-hexopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10-dihydroxy-3,17-dimethoxy-5,7,11,13-tetramethyl-, (3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-

Concanamycin C

CAS: 81552-34-3

Concanamycin C, a natural macrolide antibiotic, was initially isolated from Streptomyces and identified as an inhibitor of T-cell proliferation in response to concanavalin A (1,2). It exhibits cytotoxicity to fungi, including yeasts, by inhibiting vacuolar-type ATPases (3,4).

Formula: C₄₅H₇₄O₁₃

Colore e forma: Solid

Peso molecolare: 823.1

Ref: TM-TN7259

Concanamycin C

CAS: 81552-34-3

Formula: C₄₅H₇₄O₁₃

Peso molecolare: 823.1

Ref: 7W-GA8504

Concanamycin C

CAS: 81552-34-3

Concanamycin C is an analog of the human kinase inhibitor that has been shown to have potent anticancer activity. This compound induces apoptosis in cancer cells by inhibiting the activity of protein kinases involved in cell cycle regulation and tumor growth. Concanamycin C is a medicinal compound that has been used as a research tool in the development of novel kinase inhibitors for cancer therapy. This potent inhibitor has been shown to be effective against various types of cancer, making it a promising candidate for further investigation as an anticancer drug. Its unique properties make it an attractive target for the development of new and more effective kinase inhibitors.

Formula: C₄₅H₇₄O₁₃

Purezza: Min. 95%

Peso molecolare: 823.1 g/mol

Ref: 3D-GDA55234